Nav: Home

Save the date; Less than 6 months to The International Liver CongressTM 2017

November 30, 2016

We are delighted to invite you to attend the 52nd Annual Congress of EASL, The European Association for the Study of the Liver. The International Liver Congress™ (ILC) 2017 will be held 19-23 April, at the RAI Congress Centre, Amsterdam, The Netherlands.

With less than six months to go, media registration for The International Liver CongressTM 2017 is now open!

Media registration is free of charge for all valid press card holders or via provision of formal journalist credentials. To obtain your personalised press registration code, please email the ILC Press Office Team (ilcpressoffice@ruderfinn.co.uk). Once you have this code, you will be able to register online.

The International Liver CongressTM is a multi-disciplinary scientific event which attracts over 10,000 delegates from around the world every year. Our aim is to showcase the latest advances in hepatology and unveil a wide variety of new, innovative data to improve the management of liver disease.
-end-
Ground-breaking data will be presented at three official press conferences, there will be an on-site press centre and private rooms available for conducting interviews with key speakers and EASL Governing Board members. More information on the press office and media activities at ILC 2017 can be found on the ILC 2017 website .

The ILC Press Office Team is available to answer any questions you may have and can be contacted at: ILCpressoffice@ruderfinn.co.uk. Further information on media registration can be found here: http://ilc-congress.eu/media-registration/.

We look forward to welcoming you in Amsterdam!

European Association for the Study of the Liver

Related Liver Articles:

The liver increases by half during the day
In mammals, the liver reaches its maximum efficiency when they are active and feed.
The IT-LIVER European consortium unveils new TGF-beta functions in liver cancer
Recent research results from the European consortium IT-Liver provide a better understanding of the role of the TGF-beta cytokine in liver cancer.
New approach to liver transplantation: Using a damaged liver to replace a dying liver
There's new hope for patients with liver disease who are waiting for a donor liver to become available for transplantation.
Unlocking a liver receptor puzzle
The nuclear receptor LRH-1 acts in the liver to regulate metabolism of fat and sugar and is a target for potential diabetes drugs.
Serious liver-related condition on the rise in the US
A new analysis reveals that cirrhosis and acute on chronic liver failure (ACLF, a deterioration of liver function in patients with cirrhosis that results in the failure of one or more organs) represent a substantial and increasing health and economic burden in the United States.
Damage to tiny liver protein function leads to heart disease, fatty liver
A UCF College of Medicine researcher has identified for the first time a tiny liver protein that when disrupted can lead to the nation's top killer -- cardiovascular disease -- as well as fatty liver disease, a precursor to cancer.
Targeted treatment for liver cancer under way
Researchers at the University of Eastern Finland and Eberhard Karls Universität Tübingen have discovered a new molecular mechanism that can be used to inhibit the growth of hepatocellular carcinoma, which is the most common liver cancer.
Transplanted liver cells protect against liver failure after massive hepatectomy surgery
Because liver failure often occurs after an extensive hepatectomy, researchers using animal models investigated safer ways to transplant liver cells post-extensive hepatectomy found that rather than transplanting cells into the liver portal vein, transplantation into an extra-hepatic site, such as the intra-mesentery, a fold of membranous tissue on the posterior wall of the abdominal cavity attached to the intestinal tract, can help protect against post-operative liver failure and aid in survival of the remaining liver.
Fatty liver disease is common
Researchers have characterized the prevalence and risk factors of fatty liver disease in patients who undergo liver transplantation.
Many diabetics don't know they have serious liver disease
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world.

Related Liver Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Bias And Perception
How does bias distort our thinking, our listening, our beliefs... and even our search results? How can we fight it? This hour, TED speakers explore ideas about the unconscious biases that shape us. Guests include writer and broadcaster Yassmin Abdel-Magied, climatologist J. Marshall Shepherd, journalist Andreas Ekström, and experimental psychologist Tony Salvador.
Now Playing: Science for the People

#513 Dinosaur Tails
This week: dinosaurs! We're discussing dinosaur tails, bipedalism, paleontology public outreach, dinosaur MOOCs, and other neat dinosaur related things with Dr. Scott Persons from the University of Alberta, who is also the author of the book "Dinosaurs of the Alberta Badlands".